respiratory pathogen nucleic acid test (GenMark Diagnostics)
Structured Review
Respiratory Pathogen Nucleic Acid Test, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pathogen+testing/respiratory+pathogen+nucleic+acid+test/pmc09671206-9820-81-91
Average 90 stars, based on 1 article reviews
Images
Related Articles
Amplification:Article Title: Antibody tests for identification of current and past infection with SARS‐CoV‐2 Article Snippet: Target condition and reference standard(s) , Reference standard: Positive for COVID‐19 by a nucleic acid amplification test that had been clinically validated in our laboratory and had an emergency use authorisation (EUA) listing with the US Food and Drug Administration Threshold not stated Samples used: Not stated Timing of reference standard: Not stated Blinded to index test: yes, prior to index test Incorporated index test: no Definition of non‐COVID cases: [2a], [2b] To identify patient specimens containing other PCR‐confirmed microbes, the respiratory pathogen nucleic acid (RPNA) test was performed on Polymerase Chain Reaction:Article Title: Antibody tests for identification of current and past infection with SARS‐CoV‐2 Article Snippet: Target condition and reference standard(s) , Reference standard: Positive for COVID‐19 by a nucleic acid amplification test that had been clinically validated in our laboratory and had an emergency use authorisation (EUA) listing with the US Food and Drug Administration Threshold not stated Samples used: Not stated Timing of reference standard: Not stated Blinded to index test: yes, prior to index test Incorporated index test: no Definition of non‐COVID cases: [2a], [2b] To identify patient specimens containing other PCR‐confirmed microbes, the respiratory pathogen nucleic acid (RPNA) test was performed on Virus:Article Title: Antibody tests for identification of current and past infection with SARS‐CoV‐2 Article Snippet: Target condition and reference standard(s) , Reference standard: Positive for COVID‐19 by a nucleic acid amplification test that had been clinically validated in our laboratory and had an emergency use authorisation (EUA) listing with the US Food and Drug Administration Threshold not stated Samples used: Not stated Timing of reference standard: Not stated Blinded to index test: yes, prior to index test Incorporated index test: no Definition of non‐COVID cases: [2a], [2b] To identify patient specimens containing other PCR‐confirmed microbes, the respiratory pathogen nucleic acid (RPNA) test was performed on |

